$2.07 Billion is the total value of BVF INC/IL's 79 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 19.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPTX | Buy | REPARE THERAPEUTICS INC | $116,005,000 | +39.0% | 8,291,988 | +41.5% | 5.60% | +67.9% |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $114,194,000 | – | 21,751,284 | +100.0% | 5.52% | – | |
| RCUS | ARCUS BIOSCIENCES INC | $100,370,000 | -19.7% | 3,960,948 | 0.0% | 4.85% | -3.1% | |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $96,266,000 | +71.2% | 7,509,059 | +39.8% | 4.65% | +106.7% |
| GHRS | GH RESEARCH PLCordinary shares | $92,566,000 | -45.4% | 9,275,158 | 0.0% | 4.47% | -34.1% | |
| MRUS | Sell | MERUS N V | $92,404,000 | -15.5% | 4,081,431 | -1.3% | 4.46% | +2.1% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $81,492,000 | -46.3% | 4,138,758 | +15.4% | 3.94% | -35.2% |
| XOMA | XOMA CORP DEL | $78,660,000 | -20.4% | 3,530,543 | 0.0% | 3.80% | -3.9% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $73,445,000 | -45.8% | 4,384,805 | -3.2% | 3.55% | -34.6% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $68,612,000 | +4.1% | 3,678,947 | +22.5% | 3.31% | +25.6% |
| KURA | KURA ONCOLOGY INC | $58,725,000 | +14.0% | 3,203,783 | 0.0% | 2.84% | +37.6% | |
| ACRS | ACLARIS THERAPEUTICS INC | $55,513,000 | -19.0% | 3,976,543 | 0.0% | 2.68% | -2.2% | |
| CTIC | CTI BIOPHARMA CORP | $53,310,000 | +27.8% | 8,929,690 | 0.0% | 2.58% | +54.4% | |
| Sell | EQRX INC | $49,942,000 | +0.6% | 10,648,527 | -11.5% | 2.41% | +21.4% | |
| XENE | XENON PHARMACEUTICALS INC | $48,610,000 | -0.5% | 1,597,966 | 0.0% | 2.35% | +20.2% | |
| IONS | New | IONIS PHARMACEUTICALS INC | $47,259,000 | – | 1,276,574 | +100.0% | 2.28% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $45,347,000 | +9.0% | 2,356,934 | -1.6% | 2.19% | +31.5% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $43,961,000 | -4.8% | 2,255,588 | +24.6% | 2.12% | +14.9% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $39,742,000 | -11.8% | 1,929,201 | +37.8% | 1.92% | +6.5% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $38,569,000 | +115.3% | 2,794,859 | +74.6% | 1.86% | +160.2% |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $33,575,000 | +113.2% | 6,894,345 | +292.7% | 1.62% | +157.3% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $31,509,000 | -29.1% | 1,659,220 | +0.7% | 1.52% | -14.4% |
| Sell | CINCOR PHARMA INC | $30,980,000 | +1.8% | 1,644,393 | -5.2% | 1.50% | +22.8% | |
| OLMA | Buy | OLEMA PHARMACEUTICALS INC | $30,979,000 | -1.9% | 7,611,503 | +2.7% | 1.50% | +18.4% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $27,972,000 | -30.6% | 4,007,413 | +50.4% | 1.35% | -16.2% |
| ACIU | AC IMMUNE SA | $26,816,000 | -9.8% | 7,428,379 | 0.0% | 1.30% | +8.9% | |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $26,317,000 | -12.3% | 14,149,179 | -1.4% | 1.27% | +5.9% |
| VSTM | VERASTEM INC | $23,171,000 | -17.7% | 19,974,658 | 0.0% | 1.12% | -0.7% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $22,935,000 | -14.6% | 3,367,826 | 0.0% | 1.11% | +3.2% | |
| Buy | NUVALENT INC | $22,595,000 | +136.0% | 1,666,282 | +141.7% | 1.09% | +184.9% | |
| COGT | Buy | COGENT BIOSCIENCES INC | $20,360,000 | +77.4% | 2,257,174 | +47.3% | 0.98% | +114.2% |
| VRDN | VIRIDIAN THERAPEUTICS INC | $20,178,000 | -37.4% | 1,744,012 | 0.0% | 0.97% | -24.5% | |
| RAIN | RAIN THERAPEUTICS INC | $19,609,000 | +9.7% | 3,526,729 | 0.0% | 0.95% | +32.4% | |
| STRO | SUTRO BIOPHARMA INC | $17,964,000 | -36.6% | 3,447,946 | 0.0% | 0.87% | -23.5% | |
| JANX | Buy | JANUX THERAPEUTICS INC | $17,953,000 | +9.6% | 1,470,334 | +28.7% | 0.87% | +32.4% |
| TYRA BIOSCIENCES INC | $17,677,000 | -33.2% | 2,472,327 | 0.0% | 0.85% | -19.3% | ||
| REPL | REPLIMUNE GROUP INC | $16,196,000 | +2.9% | 926,529 | 0.0% | 0.78% | +24.3% | |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $15,278,000 | +101.2% | 3,629,000 | +61.1% | 0.74% | +142.8% |
| OVID | OVID THERAPEUTICS INC | $14,730,000 | -31.5% | 6,851,051 | 0.0% | 0.71% | -17.4% | |
| ANNX | New | ANNEXON INC | $14,253,000 | – | 3,780,694 | +100.0% | 0.69% | – |
| VIRX | VIRACTA THERAPEUTICS INC | $14,025,000 | -18.5% | 3,614,662 | 0.0% | 0.68% | -1.6% | |
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $13,478,000 | -3.0% | 750,000 | 0.0% | 0.65% | +17.1% | |
| ETNB | New | 89BIO INC | $12,552,000 | – | 3,898,000 | +100.0% | 0.61% | – |
| AN2 THERAPEUTICS INC | $12,529,000 | -48.6% | 1,616,665 | 0.0% | 0.60% | -37.9% | ||
| CFRX | CONTRAFECT CORP | $12,195,000 | -15.9% | 3,972,300 | 0.0% | 0.59% | +1.6% | |
| EPIX | Buy | ESSA PHARMA INC | $11,651,000 | -49.0% | 3,698,629 | +0.1% | 0.56% | -38.4% |
| IKNA | Buy | IKENA ONCOLOGY INC | $11,089,000 | -27.3% | 2,503,071 | +0.1% | 0.54% | -12.1% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $10,852,000 | -23.9% | 1,275,240 | -19.8% | 0.52% | -8.1% |
| AADI BIOSCIENCE INC | $10,830,000 | -27.4% | 879,085 | 0.0% | 0.52% | -12.4% | ||
| CTMX | CYTOMX THERAPEUTICS INC | $10,621,000 | -31.5% | 5,803,700 | 0.0% | 0.51% | -17.3% | |
| GBIO | Sell | GENERATION BIO CO | $10,273,000 | -50.1% | 1,556,032 | -44.5% | 0.50% | -39.7% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $9,500,000 | -41.2% | 5,080,320 | -4.7% | 0.46% | -28.9% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $8,755,000 | -91.2% | 1,106,838 | -73.5% | 0.42% | -89.3% |
| SLN | SILENCE THERAPEUTICS PLCads | $7,900,000 | -37.6% | 666,666 | 0.0% | 0.38% | -24.7% | |
| Buy | PYXIS ONCOLOGY INC | $6,994,000 | -39.5% | 2,938,851 | +2.7% | 0.34% | -27.0% | |
| GLYC | GLYCOMIMETICS INC | $5,707,000 | -47.5% | 9,544,262 | 0.0% | 0.28% | -36.6% | |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,677,000 | -38.1% | 2,326,710 | 0.0% | 0.27% | -25.3% | |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $4,555,000 | -67.4% | 4,996,565 | +23.5% | 0.22% | -60.6% |
| New | HILLEVAX INC | $4,181,000 | – | 382,513 | +100.0% | 0.20% | – | |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $4,152,000 | – | 154,000 | +100.0% | 0.20% | – |
| INFI | INFINITY PHARMACEUTICALS INC | $4,017,000 | -44.5% | 6,353,645 | 0.0% | 0.19% | -33.1% | |
| IVA | INVENTIVA SAads | $3,993,000 | -49.7% | 686,040 | 0.0% | 0.19% | -39.1% | |
| CDTX | CIDARA THERAPEUTICS INC | $3,352,000 | -41.3% | 6,861,127 | 0.0% | 0.16% | -29.3% | |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $3,237,000 | -44.4% | 2,312,200 | +0.0% | 0.16% | -33.0% |
| MOLN | MOLECULAR PARTNERS AGads | $2,983,000 | -66.8% | 443,221 | 0.0% | 0.14% | -59.9% | |
| SPRO | Buy | SPERO THERAPEUTICS INC | $2,289,000 | -83.4% | 3,089,615 | +94.9% | 0.11% | -79.9% |
| SELB | SELECTA BIOSCIENCES INC | $2,257,000 | +6.5% | 1,723,133 | 0.0% | 0.11% | +28.2% | |
| FWP | Buy | FORWARD PHARMA A/Ssponsord ads new | $2,225,000 | -11.5% | 513,791 | +18.7% | 0.11% | +5.9% |
| MEIP | MEI PHARMA INC | $2,137,000 | +0.4% | 3,532,057 | 0.0% | 0.10% | +21.2% | |
| ERYP | ERYTECH PHARMAsponsored adr | $1,440,000 | -39.8% | 1,314,656 | 0.0% | 0.07% | -27.1% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,357,000 | -39.6% | 1,370,947 | 0.0% | 0.07% | -26.7% | |
| ALRN | AILERON THERAPEUTICS INC | $1,369,000 | -49.3% | 5,265,555 | 0.0% | 0.07% | -38.9% | |
| ANGN | ANGION BIOMEDICA CORP | $1,221,000 | -46.2% | 1,071,297 | 0.0% | 0.06% | -35.2% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $1,224,000 | -57.2% | 1,799,694 | 0.0% | 0.06% | -48.2% | |
| New | CALITHERA BIOSCIENCES INC | $1,143,000 | – | 464,742 | +100.0% | 0.06% | – | |
| XFOR | X4 PHARMACEUTICALS INC | $818,000 | -44.9% | 847,879 | 0.0% | 0.04% | -32.2% | |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $827,000 | -90.9% | 140,000 | -88.2% | 0.04% | -89.0% |
| RZLT | REZOLUTE INC | $616,000 | -4.5% | 190,815 | 0.0% | 0.03% | +15.4% | |
| BIONOMICS LIMITEDads | $555,000 | -19.8% | 80,971 | 0.0% | 0.03% | -3.6% | ||
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -126,797 | -100.0% | -0.03% | – |
| ABOS | Exit | ACUMEN PHARMACEUTICALS INC | $0 | – | -289,663 | -100.0% | -0.04% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -378,000 | -100.0% | -0.13% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -9,294,923 | -100.0% | -0.15% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -4,012,404 | -100.0% | -0.20% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -809,282 | -100.0% | -0.32% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -955,000 | -100.0% | -0.58% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -1,046,283 | -100.0% | -2.60% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -316,204 | -100.0% | -3.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.